Anti-LYRIC/AEG1 antibody [EP4445]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(19 Publications)
Rabbit Recombinant Monoclonal LYRIC/AEG1 antibody. Suitable for IHC-P, WB, ICC/IF and reacts with Human, Mouse, Rat samples. Cited in 19 publications.
View Alternative Names
AEG1, LYRIC, MTDH, Protein LYRIC, 3D3/LYRIC, Astrocyte elevated gene-1 protein, Lysine-rich CEACAM1 co-isolated protein, Metadherin, Metastasis adhesion protein, AEG-1
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LYRIC/AEG1 antibody [EP4445] (AB124789)
ab124789 at 1/100 dilution staining LYRIC/AEG1 in paraffin-embedded Human breast tissues by Immunohistochemistry.
Perform heat mediated antigen retrieval before commencing with IHC staining protocol.
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-LYRIC/AEG1 antibody [EP4445] (AB124789)
Immunocytochemistry/Immunofluorescence analysis of HeLa cells labelling LYRIC/AEG1 with purified ab124789 at a dilution of 1/500. Cells were fixed with 4% paraformaldehyde and permeabilized with 0.1% Triton X-100. ab150077, an Alexa Fluor® 488-conjugated goat anti-rabbit IgG (1/1000) was used as the secondary antibody. Nuclei counterstained with DAPI (blue).
Control : PBS only.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LYRIC/AEG1 antibody [EP4445] (AB124789)
ab124789 at 1/100 dilution staining LYRIC/AEG1 in paraffin-embedded Human brain tissues by Immunohistochemistry.
Perform heat mediated antigen retrieval before commencing with IHC staining protocol.
- WB
Unknown
Western blot - Anti-LYRIC/AEG1 antibody [EP4445] (AB124789)
All lanes:
Western blot - Anti-LYRIC/AEG1 antibody [EP4445] (ab124789) at 1/10000 dilution
Lane 1:
HeLa cell lysate at 10 µg
Lane 2:
Jurkat cell lysate at 10 µg
Lane 3:
PC3 cell lysate at 10 µg
Lane 4:
PC12 cell lysate at 10 µg
Lane 5:
NIH 3T3 cell lysate at 10 µg
Secondary
All lanes:
Goat anti-Rabbit HRP at 1/2000 dilution
Predicted band size: 64 kDa
false
Related conjugates and formulations (2)
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-LYRIC/AEG1 antibody [EP4445]
-
Anti-LYRIC/AEG1 antibody [EP4445] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
LYRIC/AEG1 functions significantly in oncogenesis and tumor progression. It participates actively in gene regulation and interacts with various proteins as part of complex protein networks influencing cell survival migration and adherence. This protein is known to enhance metastasis and promote angiogenesis in malignant contexts. Researchers often study the modulation of LYRIC/AEG1 to assess its impact on cell proliferation and differentiation in cancer cells.
Pathways
LYRIC/AEG1 is associated with important signaling pathways such as the NF-κB and PI3K/Akt pathways. These pathways are critical for cell survival and proliferation and LYRIC/AEG1 modulates their activity. Through these pathways it interacts with other proteins like IκB kinase complexes and Akt coordinating cellular responses to external stimuli. LYRIC/AEG1’s influence on these pathways highlights its role in cellular adaptation to stress and potential therapeutic interventions.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (19)
Recent publications for all applications. Explore the full list and refine your search
Genomics, proteomics & bioinformatics 21:1246-1259 PubMed37121272
2023
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 24: PubMed36902125
2023
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine reports 26: PubMed36177898
2022
Applications
Unspecified application
Species
Unspecified reactive species
Proceedings of the National Academy of Sciences of the United States of America 119:e2203738119 PubMed36067288
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cancer management and research 12:8363-8377 PubMed32982430
2020
Applications
Unspecified application
Species
Unspecified reactive species
Cancer management and research 12:2947-2960 PubMed32431541
2020
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 11:221 PubMed32251289
2020
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 20: PubMed31698701
2019
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in oncology 9:847 PubMed31552174
2019
Applications
Unspecified application
Species
Unspecified reactive species
Oncology letters 17:4514-4520 PubMed30988817
2019
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com